We are live on ! Find out more
XK

Xact Kapitalforvaltning Portfolio holdings

AUM $4.7B
1-Year Est. Return 0.05%
This Fund
S&P 500
This Quarter Est. Return
+7.43%
1 Year Est. Return
-0.05%
3 Year Est. Return
+34.22%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$3.24B
AUM Growth
+$391M
Cap. Flow
+$202M
Cap. Flow %
6.24%
Top 10 Hldgs %
18.9%
Holding
641
New
4
Increased
499
Reduced
26
Closed
8

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$14.8M
2
MSFT icon
Microsoft
MSFT
+$6.3M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$5.66M
4
AAPL icon
Apple
AAPL
+$5.51M
5
BAC icon
Bank of America
BAC
+$4.62M

Top Sells

Rank Stock Value
1
WFC icon
Wells Fargo
WFC
+$19.1M
2
STJ
St Jude Medical
STJ
+$3.52M
3
LLTC
Linear Technology Corp
LLTC
+$2.57M
4
SBAC icon
SBA Communications
SBAC
+$2.32M
5
GGP
GGP Inc.
GGP
+$2.24M

Sector Composition

Rank Sector Weight
1 Technology 17.52%
2 Financials 16.29%
3 Healthcare 15.87%
4 Communication Services 11.63%
5 Consumer Discretionary 10.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IBM icon
26
IBM
IBM
$211B
$24.6M 0.76%
147,912
+5,161
+4% +$865K
BABA icon
27
Alibaba
BABA
$293B
$23.5M 0.72%
217,847
+5,310
+2% +$540K
CELG
28
DELISTED
Celgene Corp
CELG
$21.4M 0.66%
171,725
+21,839
+15% +$2.61M
GE icon
29
GE Aerospace
GE
$374B
$20.6M 0.64%
144,457
+8,875
+7% +$1.28M
WFC icon
30
Wells Fargo
WFC
$261B
$20.6M 0.64%
370,342
-336,907
-48% -$19.1M
AMGN icon
31
Amgen
AMGN
$208B
$20.2M 0.62%
123,097
+4,161
+3% +$691K
MA icon
32
Mastercard
MA
$502B
$19.3M 0.59%
171,222
+6,342
+4% +$695K
ABBV icon
33
AbbVie
ABBV
$443B
$18.2M 0.56%
278,554
+28,796
+12% +$1.81M
MDT icon
34
Medtronic
MDT
$109B
$17.9M 0.55%
222,167
+8,559
+4% +$669K
MMM icon
35
3M
MMM
$90.9B
$17.6M 0.54%
109,790
+3,815
+4% +$585K
MCD icon
36
McDonald's
MCD
$192B
$17.2M 0.53%
132,464
+4,073
+3% +$511K
AVGO icon
37
Broadcom
AVGO
$1.85T
$16M 0.49%
730,340
+70,760
+11% +$1.46M
BRK.B icon
38
Berkshire Hathaway Class B
BRK.B
$1.1T
$16M 0.49%
95,796
+7,463
+8% +$1.25M
CVX icon
39
Chevron
CVX
$392B
$15.8M 0.49%
146,957
+11,537
+9% +$1.29M
LLY icon
40
Eli Lilly
LLY
$1.02T
$15.4M 0.47%
182,791
+22,967
+14% +$1.84M
AGN
41
DELISTED
Allergan plc
AGN
$15.2M 0.47%
+63,735
New +$14.8M
BKNG icon
42
Booking.com
BKNG
$149B
$15.2M 0.47%
213,825
+9,825
+5% +$648K
BMY icon
43
Bristol-Myers Squibb
BMY
$133B
$15.1M 0.46%
277,115
+11,732
+4% +$643K
GILD icon
44
Gilead Sciences
GILD
$162B
$14.7M 0.45%
216,347
+9,360
+5% +$658K
ACN icon
45
Accenture
ACN
$102B
$14.5M 0.45%
121,362
+8,430
+7% +$1.01M
CVS icon
46
CVS Health
CVS
$133B
$14.2M 0.44%
181,089
+12,701
+8% +$1.01M
UNP icon
47
Union Pacific
UNP
$174B
$14.2M 0.44%
133,738
+10,045
+8% +$1.07M
GS icon
48
Goldman Sachs
GS
$300B
$14.1M 0.44%
61,576
+6,619
+12% +$1.6M
QCOM icon
49
Qualcomm
QCOM
$155B
$13.8M 0.43%
240,333
+8,559
+4% +$497K
SBUX icon
50
Starbucks
SBUX
$120B
$13.7M 0.42%
235,429
+7,896
+3% +$447K
1
2
3 4 5

Similar funds

HFA
Harvest Fund Advisors Wayne, Pennsylvania $4.87B AUM 49.03% 1-Year Est. Return
BPSG
Brookfield Public Securities Group New York $6.17B AUM
PIA
Piedmont Investment Advisors Durham, North Carolina $2.53B AUM 0.83% 1-Year Est. Return
FTIOP
Fiduciary Trust International of Pennsylvania Radnor, Pennsylvania $2.14B AUM 3.72% 1-Year Est. Return
CEP
Chicago Equity Partners Chicago, Illinois $993M AUM 6.42% 1-Year Est. Return
EA
Echinus Advisors New York $881M AUM 6.76% 1-Year Est. Return
OWD
Osborn Williams & Donohoe Cincinnati, Ohio $762M AUM 2.74% 1-Year Est. Return
AVC
Arlington Value Capital Salt Lake City, Utah $688M AUM 23.52% 1-Year Est. Return

Xact Kapitalforvaltning's Q1 2017 Portfolio in Review

As of Q1 2017, Xact Kapitalforvaltning held 641 positions worth $3.24B, up 14% from $2.85B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Xact Kapitalforvaltning deployed $202M of net new capital in Q1 2017, opening 4 new positions and adding to 499 existing holdings. Its largest new stake was Allergan plc: 63,735 shares worth $15.2M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Wells Fargo, an estimated $19.1M trimmed.

  • Xact Kapitalforvaltning's largest Q1 2017 buy was Allergan plc: 63,735 shares worth $15.2M.
  • Xact Kapitalforvaltning added most to Microsoft in Q1 2017, an estimated $6.3M increase.
  • Xact Kapitalforvaltning's biggest Q1 2017 reduction was Wells Fargo, cutting an estimated $19.1M.
  • Xact Kapitalforvaltning fully exited St Jude Medical in Q1 2017, selling an estimated $3.52M.
  • Xact Kapitalforvaltning's ten largest holdings make up 19% of its $3.24B portfolio in Q1 2017.
  • Xact Kapitalforvaltning opened 4 new positions and closed 8 in Q1 2017.
  • Xact Kapitalforvaltning's portfolio value rose 14% quarter-over-quarter to $3.24B.

Based on Xact Kapitalforvaltning's 13F filing for Q1 2017, filed 4 May 2017.